IGA 8/E Chapter 14
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Missense Mutations of MADH4: Characterization of the Mutational Hot Spot and Functional Consequences in Human Tumors
Vol. 10, 1597–1604, March 1, 2004 Clinical Cancer Research 1597 Featured Article Missense Mutations of MADH4: Characterization of the Mutational Hot Spot and Functional Consequences in Human Tumors Christine A. Iacobuzio-Donahue,1 Jason Song,5 Introduction Giovanni Parmiagiani,4 Charles J. Yeo,2,3 Human pancreatic ductal adenocarcinomas inactivate the Ralph H. Hruban,1,2 and Scott E. Kern2 tumor suppressor gene MADH4 (DPC4, SMAD4) with a high frequency (1). This inactivation occurs most commonly by Departments of 1Pathology, 2Oncology, 3Surgery, and 4Public Health, The Johns Hopkins Medical Institutions, Baltimore, Maryland, and homozygous deletion (HD), but some tumors may also inacti- 5Temple University School of Medicine, Philadelphia, Pennsylvania vate the gene by loss of heterozygosity (LOH) coupled with a mutation in the remaining allele. Inactivation by nonsense mu- tation may cause the loss of protein expression by enhanced Abstract proteosomal degradation (2, 3). Even when expressed as protein, Purpose and Experimental Design: The mutational spec- missense mutations may result in loss of a specific function of trum of MADH4 (DPC4/SMAD4) opens valuable insights the Madh4 protein such as DNA binding or Smad protein into the functions of this protein that confer its tumor- interactions (2–9). Thus, the location of these mutations can suppressive nature in human tumors. We present the provide clues to key structural features that mediate the tumor- MADH4 genetic status determined on a new set of pancre- suppressive function of MADH4. atic, biliary, and duodenal cancers with comparison to the Members of the Smad protein family, including Madh4, mutational data reported for various tumor types. -
DNA Insertion Mutations Can Be Predicted by a Periodic Probability
Research article DNA insertion mutations can be predicted by a periodic probability function Tatsuaki Tsuruyama1 1Department of Pathology, Graduate School of Medicine, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan Running title: Probability prediction of mutation Correspondence to: Tatsuaki Tsuruyama Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan Tel.: +81-75-751-3488; Fax: +81-75-761-9591 E-mail: [email protected] 1 Abstract It is generally difficult to predict the positions of mutations in genomic DNA at the nucleotide level. Retroviral DNA insertion is one mode of mutation, resulting in host infections that are difficult to treat. This mutation process involves the integration of retroviral DNA into the host-infected cellular genomic DNA following the interaction between host DNA and a pre-integration complex consisting of retroviral DNA and integrase. Here, we report that retroviral insertion sites around a hotspot within the Zfp521 and N-myc genes can be predicted by a periodic function that is deduced using the diffraction lattice model. In conclusion, the mutagenesis process is described by a biophysical model for DNA–DNA interactions. Keywords: Insertion, mutagenesis, palindromic sequence, retroviral DNA 2 Text Introduction Extensive research has examined retroviral insertions to further our understanding of DNA mutations. Retrovirus-related diseases, including leukemia/lymphoma and AIDS, develop after retroviral genome insertion into the genomic DNA of the infected host cell. Retroviral DNA insertion is one of the modes of insertional mutation. After reverse-transcription of the retroviral genomic RNA into DNA, the retroviral DNA forms a pre-insertion complex (PIC) with the integrase enzyme, which catalyzes the insertion reaction. -
DNA Sequence Insertion and Evolutionary Variation in Gene Regulation (Mobile Elements/Long Terminal Repeats/Alu Sequences/Factor-Binding Sites) Roy J
Proc. Natl. Acad. Sci. USA Vol. 93, pp. 9374-9377, September 1996 Colloquium Paper This paper was presented at a colloquium entitled "Biology of Developmental Transcription Control, " organized by Eric H. Davidson, Roy J. Britten, and Gary Felsenfeld, held October 26-28, 1995, at the National Academy of Sciences in Irvine, CA. DNA sequence insertion and evolutionary variation in gene regulation (mobile elements/long terminal repeats/Alu sequences/factor-binding sites) RoY J. BRITrEN Division of Biology, California Institute of Technology, 101 Dahlia Avenue, Corona del Mar, CA 92625 ABSTRACT Current evidence on the long-term evolution- 3 and 4). Sequence change, obscuring the original structure, ary effect of insertion of sequence elements into gene regions has occurred in the long history, and the underlying rate of is reviewed, restricted to cases where a sequence derived from base substitution that is responsible is known (5). a past insertion participates in the regulation of expression of The requirements for a convincing example are: (i) that a useful gene. Ten such examples in eukaryotes demonstrate there be a trace of a known class of elements present in gene that segments of repetitive DNA or mobile elements have been region; (ii) that there is evidence that it has been there long inserted in the past in gene regions, have been preserved, enough to not just be a transient mutation; (iii) that some sometimes modified by selection, and now affect control of sequence residue of the mobile element or repeat participates transcription ofthe adjacent gene. Included are only examples in regulation of expression of the gene; (iv) that the gene have in which transcription control was modified by the insert. -
Genetic Analysis of the Transition from Wild to Domesticated Cotton (G
bioRxiv preprint doi: https://doi.org/10.1101/616763; this version posted April 23, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Genetic analysis of the transition from wild to domesticated cotton (G. hirsutum) Corrinne E. Grover1, Mi-Jeong Yoo1,a, Michael A. Gore2, David B. Harker3,b, Robert L. Byers3, Alexander E. Lipka4, Guanjing Hu1, Daojun Yuan1, Justin L. Conover1, Joshua A. Udall3,c, Andrew H. Paterson5, and Jonathan F. Wendel1 1Department of Ecology, Evolution and Organismal Biology, Iowa State University, Ames, IA 50011 2Plant Breeding and Genetics Section, School of Integrative Plant Science, Cornell University, Ithaca, NY 14853 3Plant and Wildlife Science Department, Brigham Young University, Provo, UT 84602 4Department of Crop Sciences, University of Illinois, Urbana, IL 61801 5Plant Genome Mapping Laboratory, University of Georgia, Athens, GA 30602 acurrent address: Department of Biology, University of Florida, Gainesville, FL 32611 bcurrent address: Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas, TX 75390 ccurrent address: Southern Plains Agricultural Research Center, USDA-ARS, College Station, TX, 77845- 4988 Corresponding Author: Jonathan F. Wendel ([email protected]) Data Availability: All data are available via figshare (https://figshare.com/projects/Genetic_analysis_of_the_transition_from_wild_to_domesticated_cotton_G _hirsutum_QTL/62693) and GitHub (https://github.com/Wendellab/QTL_TxMx). Keywords: QTL, domestication, Gossypium hirsutum, cotton Summary: An F2 population between truly wild and domesticated cotton was used to identify QTL associated with selection under domestication. -
Principles and Methods for the Risk Assessment of Chemicals in Food
WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE EHC240: Principles and Methods for the Risk Assessment of Chemicals in Food SUBCHAPTER 4.5. Genotoxicity Draft 12/12/2019 Deadline for comments 31/01/2020 The contents of this restricted document may not be divulged to persons other than those to whom it has been originally addressed. It may not be further distributed nor reproduced in any manner and should not be referenced in bibliographical matter or cited. Le contenu du présent document à distribution restreinte ne doit pas être divulgué à des personnes autres que celles à qui il était initialement destiné. Il ne saurait faire l’objet d’une redistribution ou d’une reproduction quelconque et ne doit pas figurer dans une bibliographie ou être cité. Hazard Identification and Characterization 4.5 Genotoxicity ................................................................................. 3 4.5.1 Introduction ........................................................................ 3 4.5.1.1 Risk Analysis Context and Problem Formulation .. 5 4.5.2 Tests for genetic toxicity ............................................... 14 4.5.2.2 Bacterial mutagenicity ............................................. 18 4.5.2.2 In vitro mammalian cell mutagenicity .................... 18 4.5.2.3 In vivo mammalian cell mutagenicity ..................... 20 4.5.2.4 In vitro chromosomal damage assays .................. 22 4.5.2.5 In vivo chromosomal damage assays ................... 23 4.5.2.6 In vitro DNA damage/repair assays ....................... 24 4.5.2.7 In vivo DNA damage/repair assays ....................... 25 4.5.3 Interpretation of test results ......................................... 26 4.5.3.1 Identification of relevant studies............................. 27 4.5.3.2 Presentation and categorization of results ........... 30 4.5.3.3 Weighting and integration of results ..................... -
DNA Repair and Synthetic Lethality
Int J Oral Sci (2011) 3:176-179. www.ijos.org.cn REVIEW DNA repair and synthetic lethality Gong-she Guo1, Feng-mei Zhang1, Rui-jie Gao2, Robert Delsite4, Zhi-hui Feng1,3*, Simon N. Powell4* 1School of Public Health, Shandong University, Jinan 250012, China; 2Second People’s Hospital of Weifang, Weifang 261041, China; 3Department of Radiation Oncology, Washington University in St Louis, St Louis MO 63108, USA; 4Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York NY 10065, USA Tumors often have DNA repair defects, suggesting additional inhibition of other DNA repair pathways in tumors may lead to synthetic lethality. Accumulating data demonstrate that DNA repair-defective tumors, in particular homologous recombination (HR), are highly sensitive to DNA-damaging agents. Thus, HR-defective tumors exhibit potential vulnerability to the synthetic lethality approach, which may lead to new therapeutic strategies. It is well known that poly (adenosine diphosphate (ADP)-ribose) polymerase (PARP) inhibitors show the synthetically lethal effect in tumors defective in BRCA1 or BRCA2 genes encoded proteins that are required for efficient HR. In this review, we summarize the strategies of targeting DNA repair pathways and other DNA metabolic functions to cause synthetic lethality in HR-defective tumor cells. Keywords: DNA repair; homologous recombination; synthetic lethality; BRCA; Rad52 International Journal of Oral Science (2011) 3: 176-179. doi: 10.4248/IJOS11064 Introduction polymerase (PARP) inhibitors are specifically toxic to homologous recombination (HR)-defective cells [3-4]. Synthetic lethality is defined as a genetic combination Playing a key role in maintaining genetic stability, HR is of mutations in two or more genes that leads to cell a major repair pathway for double-strand breaks (DSBs) death, whereas a mutation in any one of the genes does utilizing undamaged homologous DNA sequence [5-6]. -
Insertion Element (IS1 Insertion Sequence/Chloramphenicol Resistance Transposon Tn9/Integrative Recombination) L
Proc. Nati. Acad. Sci. USA Vol. 75, No. 3, pp. 1490-1494, March 1978 Genetics Chromosomal integration of phage X by means of a DNA insertion element (IS1 insertion sequence/chloramphenicol resistance transposon Tn9/integrative recombination) L. A. MACHATTIE AND J. A. SHAPIRO Department of Microbiology, University of Chicago, Chicago, Illinois 60637 Communicated by Albert Dorfman, January 10, 1978 ABSTRACT Phage Xcamll2, which contains the chlor- carries a deletion of the gal-attB-bio region of the Escherichia amphenicol resistance transposon Tn9 and has a deletion of attP coil chromosome. MGBO is a gal+bio+ transductant of and the int gene, will lysogenize Escherichia coli K-12. Pro- phage integration occurs at different chromosomal sites, in- MADO. MS6 is a galE indicator for detection of XgalE + T- cluding lacYand maiB, but not at attB. All Xcamll2 prophages transducing particles and S1653 is a gal deletion strain for de- are excised from the chromosome after induction but with tection of Xgal + particles (3). Strain 200PS is a thi lacY strain various efficiencies for different locations. Heteroduplex from the Pasteur collection. Strain QL carries a complete lac analysis of XplacZ transducing phages isolated from a lacY:: deletion, strain X9003 carries the nonpolar M15 lacZ deletion, Xcamll2 prophage reveals an insertion sequence 1 (IS1) element and either will serve as indicator for XplacZ phage in a blue at theloint of viral and chromosomal DNA. Two lines of evi- dencekdicate that Xcamll2 encodes an excision activity that plaque assay (8). recognizes the ISI element: (i) prophage derepression increases Media. Our basic minimal medium and complete TYE the frequency of excision from IacYto yield lac+ revertants, and medium have been described (9). -
A Gain-Of-Function P53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia Through the Pluripotency Factor FOXH1
Published OnlineFirst May 8, 2019; DOI: 10.1158/2159-8290.CD-18-1391 RESEARCH ARTICLE A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1 Evangelia Loizou1,2, Ana Banito1, Geulah Livshits1, Yu-Jui Ho1, Richard P. Koche3, Francisco J. Sánchez-Rivera1, Allison Mayle1, Chi-Chao Chen1, Savvas Kinalis4, Frederik O. Bagger4,5, Edward R. Kastenhuber1,6, Benjamin H. Durham7, and Scott W. Lowe1,8 Downloaded from cancerdiscovery.aacrjournals.org on September 27, 2021. © 2019 American Association for Cancer Research. Published OnlineFirst May 8, 2019; DOI: 10.1158/2159-8290.CD-18-1391 ABSTRACT Mutations in the TP53 tumor suppressor gene are common in many cancer types, including the acute myeloid leukemia (AML) subtype known as complex karyotype AML (CK-AML). Here, we identify a gain-of-function (GOF) Trp53 mutation that accelerates CK-AML initiation beyond p53 loss and, surprisingly, is required for disease maintenance. The Trp53 R172H muta- tion (TP53 R175H in humans) exhibits a neomorphic function by promoting aberrant self-renewal in leu- kemic cells, a phenotype that is present in hematopoietic stem and progenitor cells (HSPC) even prior to their transformation. We identify FOXH1 as a critical mediator of mutant p53 function that binds to and regulates stem cell–associated genes and transcriptional programs. Our results identify a context where mutant p53 acts as a bona fi de oncogene that contributes to the pathogenesis of CK-AML and suggests a common biological theme for TP53 GOF in cancer. SIGNIFICANCE: Our study demonstrates how a GOF p53 mutant can hijack an embryonic transcrip- tion factor to promote aberrant self-renewal. -
IN EVOLUTION JACK LESTER KING UNIVERSITY of CALIFORNIA, SANTA BARBARA This Paper Is Dedicated to Retiring University of California Professors Curt Stern and Everett R
THE ROLE OF MUTATION IN EVOLUTION JACK LESTER KING UNIVERSITY OF CALIFORNIA, SANTA BARBARA This paper is dedicated to retiring University of California Professors Curt Stern and Everett R. Dempster. 1. Introduction Eleven decades of thought and work by Darwinian and neo-Darwinian scientists have produced a sophisticated and detailed structure of evolutionary ,theory and observations. In recent years, new techniques in molecular biology have led to new observations that appear to challenge some of the basic theorems of classical evolutionary theory, precipitating the current crisis in evolutionary thought. Building on morphological and paleontological observations, genetic experimentation, logical arguments, and upon mathematical models requiring simplifying assumptions, neo-Darwinian theorists have been able to make some remarkable predictions, some of which, unfortunately, have proven to be inaccurate. Well-known examples are the prediction that most genes in natural populations must be monomorphic [34], and the calculation that a species could evolve at a maximum rate of the order of one allele substitution per 300 genera- tions [13]. It is now known that a large proportion of gene loci are polymorphic in most species [28], and that evolutionary genetic substitutions occur in the human line, for instance, at a rate of about 50 nucleotide changes per generation [20], [24], [25], [26]. The puzzling observation [21], [40], [46], that homologous proteins in different species evolve at nearly constant rates is very difficult to account for with classical evolutionary theory, and at the very least gives a solid indication that there are qualitative differences between the ways molecules evolve and the ways morphological structures evolve. -
Bio 102 Practice Problems Genetic Code and Mutation
Bio 102 Practice Problems Genetic Code and Mutation Multiple choice: Unless otherwise directed, circle the one best answer: 1. Choose the one best answer: Beadle and Tatum mutagenized Neurospora to find strains that required arginine to live. Based on the classification of their mutants, they concluded that: A. one gene corresponds to one protein. B. DNA is the genetic material. C. "inborn errors of metabolism" were responsible for many diseases. D. DNA replication is semi-conservative. E. protein cannot be the genetic material. 2. Choose the one best answer. Which one of the following is NOT part of the definition of a gene? A. A physical unit of heredity B. Encodes a protein C. Segement of a chromosome D. Responsible for an inherited characteristic E. May be linked to other genes 3. A mutation converts an AGA codon to a TGA codon (in DNA). This mutation is a: A. Termination mutation B. Missense mutation C. Frameshift mutation D. Nonsense mutation E. Non-coding mutation 4. Beadle and Tatum performed a series of complex experiments that led to the idea that one gene encodes one enzyme. Which one of the following statements does not describe their experiments? A. They deduced the metabolic pathway for the synthesis of an amino acid. B. Many different auxotrophic mutants of Neurospora were isolated. C. Cells unable to make arginine cannot survive on minimal media. D. Some mutant cells could survive on minimal media if they were provided with citrulline or ornithine. E. Homogentisic acid accumulates and is excreted in the urine of diseased individuals. 5. -
FDA Genetic Toxicology Workshop How Many Doses of an Ames
FDA Genetic Toxicology Workshop How many doses of an Ames- Positive/Mutagenic (DNA Reactive) Drug can be safely administered to Healthy Subjects? November 4, 2019 Enrollment of Healthy Subjects into First-In-Human phase 1 clinical trials • Healthy subjects are commonly enrolled into First-In-Human (FIH) phase 1 clinical trials of new drug candidates. • Studies are typically short (few days up to 2 weeks) • Treatment may be continuous or intermittent (e.g., washout period of 5 half- lives between doses) • Receive no benefits and potentially exposed to significant health risks • Patients will be enrolled in longer phase 2 and 3 trials • Advantages of conducting trials with healthy subjects include: • investigation of pharmacokinetics (PK)/bioavailability in the absence of other potentially confounding drugs • data not confounded by disease • Identification of maximum tolerated dose • reduction in patient exposure to ineffective drugs or doses • rapid subject accrual into a study 2 Supporting Nonclinical Pharmacology and Toxicology Studies • The supporting nonclinical data package for a new IND includes • pharmacology studies (in vitro and in vivo) • safety pharmacology studies (hERG, ECG, cardiovascular, and respiratory) • secondary pharmacology studies • TK/ADME studies (in vitro and in vivo) • 14- to 28-day toxicology studies in a rodent and non-rodent • standard battery of genetic toxicity studies (Ames bacterial reverse mutation assay, in vitro mammalian cell assay, and an in vivo micronucleus assay) • Toxicology studies are used to • select clinical doses that are adequately supported by the data • assist with clinical monitoring • Genetic toxicity studies are used for hazard identification • Cancer drugs are often presumed to be genotoxic and genetic toxicity studies are generally not required for clinical trials in cancer patients. -
Experiments on the Role of Deleterious Mutations As Stepping Stones In
Experiments on the role of deleterious mutations as PNAS PLUS stepping stones in adaptive evolution Arthur W. Covert IIIa,b,c,d, Richard E. Lenskia,c,e,1, Claus O. Wilkec,d, and Charles Ofriaa,b,c,1 aProgram in Ecology, Evolutionary Biology and Behavior, Departments of bComputer Science and Engineering and eMicrobiology and Molecular Genetics, and cBEACON Center for the Study of Evolution in Action, Michigan State University, East Lansing, MI 48824; and dCenter for Computational Biology, Institute for Cellular and Molecular Biology, and Department of Integrative Biology, University of Texas at Austin, Austin, TX 78712 Contributed by Richard E. Lenski, July 16, 2013 (sent for review April 22, 2013) Many evolutionary studies assume that deleterious mutations spread unless they are tightly linked (5, 6). In an asexual pop- necessarily impede adaptive evolution. However, a later mutation ulation, however, the fortuitous combination, once formed, will that is conditionally beneficial may interact with a deleterious be stably inherited, thereby providing a simple way to traverse a predecessor before it is eliminated, thereby providing access to fitness valley (5–10). adaptations that might otherwise be inaccessible. It is unknown Previous research on a variety of systems, both biological and whether such sign-epistatic recoveries are inconsequential events computational, has documented many examples of epistatic inter- or an important factor in evolution, owing to the difficulty of actions between mutations (3, 6, 11, 14–24), including a few cases monitoring the effects and fates of all mutations during experi- of mutational pairs that are individually deleterious but jointly ments with biological organisms.